David S. Barlow
Chief Executive Officer at Psy Therapeutics, Inc.
Profile
David S.
Barlow is currently the Chairman & Chief Executive Officer of Psy Therapeutics, Inc., Director of The California Wellness Foundation, and Trustee of Bates College.
He previously served as Chairman of McLean Hospital, Inc., Director of Enzon Pharmaceuticals, Inc., and Director of New River Pharmaceuticals, Inc. from 2000 to 2012.
He was also a Director of Molecular Insight Pharmaceuticals, Inc. from 2000 to 2008.
Additionally, he served as a Member of the President's Council at The General Hospital Corp.
Mr. Barlow holds an MBA from Stanford University.
David S. Barlow active positions
| Companies | Position | Start |
|---|---|---|
| Bates College | Director/Board Member | - |
| The California Wellness Foundation | Director/Board Member | - |
Psy Therapeutics, Inc.
 Psy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Psy Therapeutics, Inc. develops novel medicines for central nervous system disorders. The firm focuses on anxiety, depression and dementia. The company was founded by Brant Binder, Maurizio Fava, Roy Perlis and Jerry Rosenbaum and is headquartered in Boston, MA. | Chief Executive Officer | - |
Former positions of David S. Barlow
| Companies | Position | End |
|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Director/Board Member | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Director/Board Member | 30/12/2008 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Chairman | - |
| ENZON PHARMACEUTICALS, INC. | Director/Board Member | - |
Training of David S. Barlow
| Stanford University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Health Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
| The California Wellness Foundation | Commercial Services |
Psy Therapeutics, Inc.
Psy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Psy Therapeutics, Inc. develops novel medicines for central nervous system disorders. The firm focuses on anxiety, depression and dementia. The company was founded by Brant Binder, Maurizio Fava, Roy Perlis and Jerry Rosenbaum and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- David S. Barlow
